Thomas Daniel 4

4 · SELECT MEDICAL HOLDINGS CORP · Filed Jul 1, 2026

AI-generated summary of this filing

Updated Jul 1, 2026

Select Medical (SEM) Director Thomas Daniel Sells 80,035 Shares

What Happened

Thomas Daniel, a director of Select Medical Holdings Corp (SEM), had 80,035 shares disposed to the issuer on 2026-06-30 as part of the company’s merger. The shares were converted into cash at $16.50 per share, for total consideration of $1,320,578. This was a disposition (sale/conversion), not an open-market purchase.

Key Details

Transaction date and price: 2026-06-30 at $16.50 per share.
Total proceeds: $1,320,578.
Transaction type/code: Disposition to issuer (D) — conversion under the merger agreement, not a voluntary market sale.
Shares owned after transaction: Not specified in the filing; footnotes indicate all outstanding and restricted shares held by the reporting person were converted into the merger consideration (implying no remaining converted shares).
Footnotes: F1 — conversion per Merger Agreement dated March 2, 2026; F2 — unvested restricted shares vested immediately before the merger and were converted, net of any required tax withholding.
Filing timeliness: Reported 2026-07-01 for a 2026-06-30 transaction (filed promptly, not flagged late).

Context

This disposition arose from the company’s merger (each share converted to $16.50 cash). Such merger-related conversions are routine corporate events and don’t necessarily reflect the director’s personal trading intent.

Form 4Exit

Period: 2026-06-30

Director

Transactions

Disposition to Issuer
Common Stock
[F1][F2]
2026-06-30$16.50/sh−80,035$1,320,578→ 0 total

Footnotes (2)

[F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
[F2]Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.

Signature

/s/ John F. Duggan, Attorney-in-Fact|2026-07-01

2 files